McGill University Health Centre, Montreal, QC, Canada.
Meakins-Christie Laboratories, Montreal, QC, Canada.
Front Immunol. 2018 Sep 20;9:2128. doi: 10.3389/fimmu.2018.02128. eCollection 2018.
Parasitic helminths are among the most pervasive pathogens of the animal kingdom. To complete their life cycle, these intestinal worms migrate through host tissues causing significant damage in their wake. As a result, infection can lead to malnutrition, anemia and increased susceptibility to co-infection. Despite repeated deworming treatment, individuals living in endemic regions remain highly susceptible to re-infection by helminths, but rarely succumb to excessive tissue damage. The chronicity of infection and inability to resist numerous species of parasitic helminths that have co-evolved with their hosts over millenia suggests that mammals have developed mechanisms to tolerate this infectious disease. Distinct from resistance where the goal is to destroy and eliminate the pathogen, disease tolerance is an active process whereby immune and structural cells restrict tissue damage to maintain host fitness without directly affecting pathogen burden. Although disease tolerance is evolutionary conserved and has been well-described in plant systems, only recently has this mode of host defense, in its strictest sense, begun to be explored in mammals. In this review, we will examine the inter- and intracellular networks that support disease tolerance during enteric stages of parasitic helminth infection and why this alternative host defense strategy may have evolved to endure the presence of non-replicating pathogens and maintain the essential functions of the intestine.
寄生虫是动物王国中最普遍存在的病原体之一。为了完成它们的生命周期,这些肠道蠕虫会迁移到宿主组织中,在它们经过的地方造成严重的损伤。因此,感染会导致营养不良、贫血和更容易合并感染。尽管反复进行驱虫治疗,生活在流行地区的人仍然容易受到寄生虫再次感染,但很少会因过度的组织损伤而屈服。感染的慢性和无法抵抗与宿主共同进化了数千年的多种寄生虫,表明哺乳动物已经发展出了耐受这种传染病的机制。与旨在破坏和消除病原体的抗性不同,疾病耐受是一种主动的过程,其中免疫和结构细胞限制组织损伤,以维持宿主的适应性,而不会直接影响病原体负担。尽管疾病耐受在进化上是保守的,并且在植物系统中已经得到了很好的描述,但直到最近,这种宿主防御方式才在哺乳动物中被严格地探索。在这篇综述中,我们将探讨在寄生虫感染的肠道阶段支持疾病耐受的细胞内和细胞间网络,以及为什么这种替代宿主防御策略可能已经进化到能够忍受非复制病原体的存在并维持肠道的基本功能。